Acadian Asset Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $589K | Sell |
1,492,552
-197,558
| -12% | -$78K | ﹤0.01% | 1102 |
|
2025
Q1 | $585K | Buy |
1,690,110
+1,531,994
| +969% | +$530K | ﹤0.01% | 1054 |
|
2024
Q4 | $92K | Buy |
+158,116
| New | +$92K | ﹤0.01% | 1379 |
|
2024
Q3 | – | Sell |
-75,031
| Closed | -$102K | – | 2086 |
|
2024
Q2 | $102K | Sell |
75,031
-80,157
| -52% | -$109K | ﹤0.01% | 1534 |
|
2024
Q1 | $532K | Buy |
155,188
+56,748
| +58% | +$195K | ﹤0.01% | 988 |
|
2023
Q4 | $241K | Buy |
+98,440
| New | +$241K | ﹤0.01% | 1198 |
|
2023
Q2 | – | Sell |
-92,683
| Closed | -$247K | – | 1729 |
|
2023
Q1 | $247K | Buy |
92,683
+38,580
| +71% | +$103K | ﹤0.01% | 1214 |
|
2022
Q4 | $446K | Sell |
54,103
-45,371
| -46% | -$374K | ﹤0.01% | 1068 |
|
2022
Q3 | $765K | Sell |
99,474
-53,023
| -35% | -$408K | ﹤0.01% | 871 |
|
2022
Q2 | $435K | Buy |
+152,497
| New | +$435K | ﹤0.01% | 1018 |
|